rs104893970
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_001358530.2(MOCS1):c.217C>T(p.Arg73Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000856 in 1,612,236 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001358530.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MOCS1 | NM_001358530.2 | c.217C>T | p.Arg73Trp | missense_variant | Exon 2 of 11 | ENST00000340692.10 | NP_001345459.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152184Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000641 AC: 16AN: 249500Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135434
GnomAD4 exome AF: 0.0000877 AC: 128AN: 1460052Hom.: 0 Cov.: 30 AF XY: 0.0000881 AC XY: 64AN XY: 726258
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152184Hom.: 0 Cov.: 31 AF XY: 0.0000538 AC XY: 4AN XY: 74320
ClinVar
Submissions by phenotype
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A Pathogenic:4
- -
Variant summary: MOCS1 c.217C>T (p.Arg73Trp) results in a non-conservative amino acid change located in the Elp3/MiaA/NifB-like, radical SAM core domain (IPR006638) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6.4e-05 in 249500 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in MOCS1 causing Sulfite Oxidase Deficiency Due To Molybdenum Cofactor Deficiency Type A (6.4e-05 vs ND), allowing no conclusion about variant significance. c.217C>T has been reported in the literature in homozygote and compound heterozygous individuals affected with Sulfite Oxidase Deficiency Due To Molybdenum Cofactor Deficiency Type A (examples: Reiss_1998, Gumus_2010, Wu_2021). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 9921896, 20573177, 33840416). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, classifying the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 73 of the MOCS1 protein (p.Arg73Trp). This variant is present in population databases (rs104893970, gnomAD 0.03%). This missense change has been observed in individuals with molybdenum cofactor deficiency (PMID: 9921896, 20573177, 35192225; internal data). ClinVar contains an entry for this variant (Variation ID: 6121). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Inborn genetic diseases Uncertain:1
The c.217C>T (p.R73W) alteration is located in exon 1 (coding exon 1) of the MOCS1 gene. This alteration results from a C to T substitution at nucleotide position 217, causing the arginine (R) at amino acid position 73 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at